Back to mobile site

UPDATE: Baird Upgrades Biogen (BIIB) to Outperform

September 28, 2022 3:31 AM EDT Send to a Friend
(Updated - September 28, 2022 6:54 AM EDT)

Baird analyst Brian Skorney upgraded Biogen (NASDAQ: BIIB) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login